Migraine must be taken 本気で as waiting times for 治療 rise - charity

The time people are waiting to be 扱う/治療するd for migraines has almost 二塁打d in England, によれば a new 報告(する)/憶測, with a charity calling for the “debilitating and stigmatised” 条件 to be taken 本気で by clinicians.

The Migraine 信用 said there should be greater 認識/意識性 of the pathways that 存在する for managing migraines, which can 原因(となる) 厳しい 苦痛 同様に as nausea, 混乱 and blurred 見通し.

It also said it should be taken 本気で and not misunderstood as “just a 頭痛”.

10 million

The number of adults in the UK 概算の to be 影響する/感情d by migraine (The Migraine 信用)

One in seven adults ? or 10 million people ? in the UK are thought to be 影響する/感情d by migraines.

More than one million have chronic migraine, which means they experience 頭痛s for at least 15 days of the month.

Data 得るd 経由で a Freedom of (警察などへの)密告,告訴(状) 行為/法令/行動する request by the Migraine 信用 明らかにする/漏らすd waiting times for 患者s 要求するing specialist care for migraines in England have 増加するd from 15 weeks in 2021 to an 普通の/平均(する) of 29 weeks in 2023.

It also (人命などを)奪う,主張するs 接近 to new 麻薬s is 存在 “妨げるd” by wait times, along with a 欠如(する) of specialist doctors and nurses.

The Migraine 信用 報告(する)/憶測 said there are より小数の than 80 GPs specialising in migraine and 頭痛s in the UK.

78,080

The number of visits across 42 A&E department for migraine in 2021/22 (The Migraine 信用)

Robert Music, 長,指導者 (n)役員/(a)執行力のある of the Migraine 信用, said: “Not only are 患者s struggling, but poor 管理/経営 of migraine is putting unnecessary 付加 緊張する on an already struggling NHS.

“We are seeing rising A&E admissions for migraine across the UK. There is a 不足 of GPs, 顧問s and nurses specialising in 頭痛 to 会合,会う the need that we know 存在するs, and a 幅の広い 欠如(する) of understanding of the 条件, meaning 患者s are not 存在 扱う/治療するd in the 権利 place or at the 権利 time, if at all.”

によれば the Migraine 信用, there were 78,080 visits to 42 A&E departments in England in 2021/22, an 増加する of 32% on the previous year.

Hospital admissions during the period also rose by 21% to 33,562.

Dr Brendan Davies, chairman of the British 協会 for the 熟考する/考慮する of 頭痛 and a 顧問 neurologist at 王室の Stoke University Hospital, said: “Migraine is the most ありふれた of all the neurological disorders yet is vastly under recognised.

Health professionals in 最初の/主要な and 第2位 care must be 権力を与えるd to 効果的に recognise and manage migraine, and 器具/実施する the 打開s therapies we now have
Dr Brendan Davies, 顧問 neurologist

“The time has come for a 国家的に-agreed 教育の 枠組み and 質 基準 for 最初の/主要な care, as we have with other important long-称する,呼ぶ/期間/用語 反対/詐欺d itions.

“Health professionals in 最初の/主要な and 第2位 care must be 権力を与えるd to 効果的に recognise and manage migraine, and 器具/実施する the 打開s therapies we now have. This will help 減ずる the 大規模な 衝撃 migraine has on the UK 全住民, in 新規加入 to 利益ing 医療の professionals and the economy.”

Levelling up 大臣 Dehenna Davison 辞職するd from the 役割 earlier this month 予定 to her 現在進行中の 戦う/戦い with chronic migraine.

The 保守的な MP said: “Migraine 影響する/感情s so many people in the UK and yet 認識/意識性 of what it really is remains painfully 限られた/立憲的な.

“No, it is not just a 頭痛 ? it is a コンビナート/複合体 条件 that can 大いに 衝撃 individuals and their families every 選び出す/独身 day. We need to 改善する 認識/意識性 about the symptoms and challenges of migraine to help 改善する 接近 to 質 治療s and 改善する the workplace experience.”

Dehenna Davison resigned as levelling up minister last week due to chronic migraine (Stefan Rousseau/PA)

Dehenna Davison 辞職するd as levelling up 大臣 last week 予定 to chronic migraine (Stefan Rousseau/PA)

Migraine 認識/意識性 Week is running from Septem ber 24 to September 30.

出版(物) of the charity’s 報告(する)/憶測 comes days after the 国家の 学校/設ける for Health and Care Excellence (Nice) recommended rimegepant as a 治療 for 激烈な/緊急の migraine.

The soluble wafer 解散させるs under the tongue and 作品 by stopping the 解放(する) of a protein around the brain called calcitonin 遺伝子-関係のある peptide.

The 最新の 指導/手引 on rimegepant is 推定する/予想するd to 利益 about 13,000 people, Nice said, by relieving the symptoms of migraine.

It was also recommended by Nice in July as an 選択 for 妨げるing episodic migraine in adults who have at least four and より小数の than 15 attacks per month if “at least” three other 治療s have not worked.

Sorry we are not 現在/一般に 受託するing comments on this article.